Ascendis Pharma
ASND
$143.18
Share price
-1.14%
Change (1 day)
79.49%
Change (1 year)
Categories
Ascendis Pharma (ASND) - Net assets
Net assets on the balance sheet as of December 2023 : -$0.17 B
According to Ascendis Pharma
's latest financial reports the company has -$0.17 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Ascendis Pharma - Net assets on balance sheet (from 2013 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $-0.17 B | -157.11% |
| 2022-12-31 | $0.28 B | -71.82% |
| 2021-12-31 | $1.00 B | -2.99% |
| 2020-12-31 | $1.03 B | 54.22% |
| 2019-12-31 | $0.66 B | 108.79% |
| 2018-12-31 | $0.32 B | 42.55% |
| 2017-12-31 | $0.22 B | 20.88% |
| 2016-12-31 | $0.18 B | 41.31% |
| 2015-12-31 | $0.13 B | 136.15% |
| 2014-12-31 | $55.71 M | 540.27% |
| 2013-12-31 | $8.7 M | 322.78% |
| 2012-12-31 | $2.05 M | 581.6% |
| 2011-12-31 | $0.3 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Akebia Therapeutics AKBA | -$30.59 M | -81.01% | 🇺🇸 USA |
 Affimed
AFMD | $80.73 M | -150.12% | 🇩🇪 Germany |
 Advaxis ADXS | -$6.25 M | -96.13% | 🇺🇸 USA |